Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 17, 2018 (8 years ago)

Omeprazole 4 mg/mL Suspension

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN 38485, NDC 00000-0001-07

Drug: Omeprazole Category: Heartburn & Stomach Medication

Recalling firm
Duren Health Mart Pharmacy
NDC code
00000-0001-07
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0416-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Omeprazole recalls

See all
Class II · Moderate risk

Omeprazole Delayed-release Capsules

Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.

Ongoing Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 82009-022-10 D-0525-2025
Class II · Moderate risk

Omeprazole Delayed-Release Capsules

CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.

Terminated cGMP deviation Dr. Reddy's Laboratories, Inc. NDC 70000-0232-1 D-0026-2022
Class II · Moderate risk

Omeprazole Delayed Release Capsules

Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 51407-129-10 D-0312-2021

Other recalls by Duren Health Mart Pharmacy

All 2018 recalls